Tempus AI, Inc. (NASDAQ:TEM) investors will be delighted, with the company turning in some strong numbers with its latest results. Results overall were solid, with revenues arriving 5.7% better than ...

Alphabet, UnitedHealth Group, Salesforce, Oracle, ServiceNow, Palo Alto Networks, and Tempus AI are the seven Healthcare ...

Tempus AI (TEM) has recently been in the spotlight after raising its earnings guidance and reporting a substantial improvement in its financial results for Q2 2025, with revenue jumping from a year ...

A major advantage on Apple's side is the number of devices it has in people's pockets, homes, and offices. Ideally, Apple can ...

In conjunction with its better-than-expected sales growth in the second quarter, Tempus AI raised its sales outlook for this ...

Shares in health technology group Tempus AI ($TEM) raced 7% higher today after its Q2 revenues surged on cancer testing demand. Forecast Busting ...

In trading on the Nasdaq stock market as of 1:17 p.m. Central, Tempus' stock price was trading at $60.65, up 3.2% from the ...

The firm's genomics revenues more than doubled year over year, while data and services revenue increased nearly 36 percent.

Since late-April, Tradr ETFs has introduced a suite of 2X long leveraged ETFs on 12 captivating stocks, including CoreWeave ( CWVX ), Tempus AI ( TEMT ), AppLovin ( APPX ), D-Wave Quantum ( QBTX ), ...

Tempus AI (NASDAQ:TEM) stock sees a 9% pre-market gain as the company raises its 2025 revenue outlook amid strong Q2 ...

Shares of Tempus AI climbed after the company narrowed its net loss and logged higher-than-expected revenue in the second quarter, boosted by what Chief Executive Eric Lefkofsky called a significant ...

CHICAGO (AP) — CHICAGO (AP) — Tempus AI Inc. (TEM) on Friday reported a loss of $42.8 million in its second quarter. The Chicago-based company said it had a loss of 25 cents per share. Losses, ...